Government's Weird Enzyme Could Turbocharge Cancer Immune Attacks
Published Date: 10/2/2025
Notice
Summary
The National Cancer Institute has a cool new invention called Acyloxyacyl Hydrolase (AOAH) that could help fight cancer by boosting the immune system. This invention is ready for companies or researchers to license or team up on, speeding up the journey from lab to real-life treatments. If you’re in biotech or cancer research, now’s the time to jump in and make a difference!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Government AOAH Invention Open For Licensing
The National Cancer Institute (NCI) is offering a government-owned invention called Acyloxyacyl Hydrolase (AOAH) and related methods for licensing or collaboration so companies and researchers can commercialize cancer immunotherapy research. If you run or work for a biotech company or cancer research group, you can pursue a license or collaboration with NCI to develop this federally funded technology.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20424, National Cancer Institute; Notice of Meeting
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
2026-20365, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings on October 29-30, 2026, to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in areas like biochemistry, software engineering, and mental health will be affected, with no direct money changes announced but important decisions coming soon.
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19718, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding two closed virtual meetings in October 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research teams applying for grants should note these dates as they impact funding decisions but don’t involve public attendance.
Previous / Next Documents
Previous: 2025-19375, Government Owned Inventions Available for Licensing: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2
The National Institutes of Health has created new mouse models that help scientists study heart problems linked to the Casq2 gene. These special mice can turn certain genes off in a controlled way, speeding up research and drug development. Researchers and biotech companies can now license this technology to boost their work, with no immediate costs but big potential for future breakthroughs.
Next: 2025-19377, Arms Sales Notification
The Department of Defense just announced new arms sales to other countries, sharing details everyone can see. This means some nations will get new military gear soon, with clear info on costs and timing. It’s all about keeping things open and making sure the right people get the right tools at the right time.